Patent Assignment
Reel/Frame 039045/0152
Assignment of Assignor's Interest
Recorded: 2016-06-29
Pages: 4
Assignor
CYMABAY THERAPEUTICS, INC.
Executed: 2016-06-29
Assignee
DIATEX, INC.
105 ELM SPRING LANE, SAN ANTONIO, TEXAS, 78231
Covered Properties
(20)
Resolution of Alpha-(Phenoxy)Phenylacetic Acid Derivatives
Crystalline Solid and Amorphous Forms of (-)- Halofenate and Methods Related Thereto
Process for the Stereoselective Preparation of (-)-Halofenate and Derivatives Thereof
Resolution of Alpha-(Phenoxy) Phenylacetic Acid Derivatives with Naphthyl-Alkylamines
Method for Avoiding Edema in the Treatment or Prevention of Ppary-Responsive Diseases, Including Cancer
Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester
Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto
Methods for Treating Gout Flares
Methods for Treating Gout in Patients Subpopulations
Application:
13/668,024 →
Publication:
US 2013/0302305
Methods for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and a Second Urate-Lowering Agent
DCC Mediated Coupling for Halofenate Manufacture
Method for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and an Anti-Inflammatory Agent
Application:
13/862,262 →
Publication:
US 2013/0274331
Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto
Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto
Methods for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and a Second Urate-Lowering Agent
Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester
Application:
14/696,092 →
Publication:
US 2016/0075636
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
Methods for Treating Gout Flares
Application:
14/930,488 →
Publication:
US 2018/0055803
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 26, 2004
From: DAUGS, EDWARD D.
To: METABOLEX, INC.
Reel/Frame 014941/0504 →
Assignment of Assignor's Interest
Aug 17, 2006
From: DAUGS, EDWARD D.; HAGEN, ERIC J.; HANKO, JASON A.; LOUKS, DAVID H.
To: METABOLEX, INC.
Reel/Frame 018141/0578 →
Assignment of Assignor's Interest
Dec 12, 2006
From: ZHU, YAN; CHENG, PENG; CHEN, XIN; MA, JINGYUAN
To: METABOLEX, INC.
Reel/Frame 018630/0739 →
Assignment of Assignor's Interest
Dec 12, 2006
From: CHENG, PENG; MA, JINGYUAN; CHEN, XIN; ZHU, YAN
To: METABOLEX, INC.
Reel/Frame 018630/0760 →
Assignment of Assignor's Interest
Dec 12, 2006
From: CHENG, PENG; MA, JINGYUAN; CHEN, XIN; ZHU, YAN
To: METABOLEX, INC.
Reel/Frame 018630/0639 →
Assignment of Assignor's Interest
Dec 12, 2006
From: ZHU, YAN; CHENG, PENG; CHEN, XIN; MA, JINGYUAN
To: METABOLEX, INC.
Reel/Frame 018630/0653 →
Assignment of Assignor's Interest
Apr 7, 2008
From: SANDERS, MARTIN E.; KARPF, DAVID B.
To: METABOLEX, INC.
Reel/Frame 020764/0334 →
Assignment of Assignor's Interest
Apr 3, 2009
From: BROGGINI, DIEGO; ZINSER, HARMUT
To: JANSSEN PHARMACEUTIC N.V.
Reel/Frame 022500/0762 →
License
Jun 17, 2009
From: METABOLEX, INC.
To: DIATEX, INC.
Reel/Frame 022835/0388 →
Corrective Assignment to Correct the Nature of Con
Jul 16, 2009
From: METABOLEX, INC.
To: DIATEX, INC.
Reel/Frame 022973/0618 →
Assignment of Assignor's Interest
Sep 29, 2011
From: JANSSEN PHARMACEUTICA N.V
To: METABOLEX, INC.
Reel/Frame 026988/0926 →
Assignment of Assignor's Interest
May 21, 2013
From: SAHA, GOPAL CHANDRA; LAVAN, BRIAN EDWARD; ROBERTS, BRIAN K.; MCWHERTER, CHARLES A.
To: METABOLEX, INC.
Reel/Frame 030456/0172 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0356 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0383 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0608 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0181 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0107 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0080 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0049 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031516/0672 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0302 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0245 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031517/0022 →
Change of Name
Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031516/0970 →
Security Agreement
Nov 22, 2013
From: CYMABAY THERAPEUTICS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 031710/0508 →